JAZZ Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.20%

Insider Buying (Last 12 Months): $9,992,963.00

Insider Selling (Last 12 Months): $5,347,742.06

Jazz Pharmaceuticals Insider Trading History Chart

Jazz Pharmaceuticals Share Price & Price History

^$110.29

▼ -0.21 (-0.19%)

As of 06/12/2025 05:00 PM ET

Days: 30 | 90 | 365

Jazz Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/2/2025	Bruce C. Cozadd	CEO	Sell	500	$107.90	$53,950.00	438,473
5/12/2025	Seamus Mulligan	Director	Buy	1,621	$103.00	$166,963.00	101,621
5/9/2025	Seamus Mulligan	Director	Buy	100,000	$98.26	$9,826,000.00	100,000
5/1/2025	Bruce C. Cozadd	CEO	Sell	1,000	$116.35	$116,350.00	439,307
4/1/2025	Bruce C. Cozadd	CEO	Sell	1,500	$123.75	$185,625.00	440,307
3/10/2025	Patricia Carr	CAO	Sell	1,140	$137.81	$157,103.40	7,012
3/10/2025	Robert Iannone	CMO	Sell	2,403	$138.41	$332,599.23	79,621
3/7/2025	Robert Iannone	CMO	Sell	7,080	$138.60	$981,288.00	82,024
3/3/2025	Bruce C. Cozadd	CEO	Sell	6,500	$144.25	$937,625.00	464,058
2/27/2025	Neena M. Patil	EVP	Sell	3,800	$144.87	$550,506.00	33,318
2/27/2025	Patricia Carr	CAO	Sell	4,813	$144.42	$695,093.46	8,237
2/3/2025	Bruce C. Cozadd	CEO	Sell	1,500	$122.31	$183,465.00	439,744
1/2/2025	Bruce C. Cozadd	CEO	Sell	1,500	$123.43	$185,145.00	425,525
12/2/2024	Bruce C. Cozadd	CEO	Sell	2,000	$121.17	$242,340.00	427,025
12/2/2024	Patricia Carr	CAO	Sell	53	$122.49	$6,491.97	6,596
11/8/2024	Neena M. Patil	EVP	Sell	3,700	$123.41	$456,617.00	33,048
11/1/2024	Bruce C. Cozadd	CEO	Sell	1,000	$110.84	$110,840.00	428,976
9/6/2024	Mary Elizabeth Henderson	SVP	Sell	1,410	$108.30	$152,703.00	14,531
6/7/2024	Patricia Carr	CAO	Sell	163	$108.83	$17,739.29	6,596
5/3/2024	Neena M. Patil	EVP	Sell	5,000	$109.65	$548,250.00	36,629
3/6/2024	Patricia Carr	CAO	Sell	1,936	$119.64	$231,623.04	8,364
3/1/2024	Philip L. Johnson	CFO	Buy	12,000	$119.65	$1,435,800.00	27,932
12/4/2023	Mark Douglas Smith	Director	Sell	417	$119.27	$49,735.59	6,888
9/1/2023	Neena M. Patil	EVP	Sell	1,500	$144.25	$216,375.00	29,186
8/29/2023	Patricia Carr	CAO	Sell	142	$143.47	$20,372.74	5,986
8/15/2023	Neena M. Patil	EVP	Sell	750	$139.59	$104,692.50	30,686
8/14/2023	Patricia Carr	CAO	Sell	158	$138.16	$21,829.28	6,128
8/14/2023	Rick E. Winningham	Director	Sell	1,241	$138.16	$171,456.56	10,444
6/7/2023	Patricia Carr	CAO	Sell	126	$127.92	$16,117.92	6,286
6/1/2023	Neena M. Patil	EVP	Sell	1,600	$127.98	$204,768.00	32,826
5/18/2023	Renée D. Galá	CFO	Sell	6,000	$131.75	$790,500.00	35,978
3/15/2023	Patricia Carr	CAO	Sell	1,023	$133.22	$136,284.06	6,286
3/8/2023	Kim Sablich	EVP	Sell	3,013	$139.74	$421,036.62	30,560
3/7/2023	Kenneth W. O'Keefe	Director	Sell	2,690	$138.39	$372,269.10	22,889
3/6/2023	Finbar Larkin	SVP	Sell	1,706	$143.92	$245,527.52	23,854
3/5/2023	Patricia Carr	CAO	Sell	1,148	$140.76	$161,592.48	7,309
2/1/2023	Bruce C. Cozadd	CEO	Sell	1,000	$155.79	$155,790.00	367,078
1/3/2023	Bruce C. Cozadd	CEO	Sell	3,000	$159.86	$479,580.00	368,078
1/3/2023	Samantha Pearce	SVP	Sell	531	$159.59	$84,742.29	11,309
12/21/2022	Renée D. Galá	CFO	Sell	2,635	$160.00	$421,600.00	32,558
12/13/2022	Samantha Pearce	SVP	Sell	531	$155.45	$82,543.95	11,309
12/9/2022	Robert Iannone	EVP	Sell	1,844	$151.54	$279,439.76	36,316
12/5/2022	Patricia Carr	CAO	Sell	63	$152.06	$9,579.78	5,934
12/2/2022	Jennifer E. Cook	Director	Sell	420	$154.68	$64,965.60	5,471
12/1/2022	Bruce C. Cozadd	CEO	Sell	1,000	$157.00	$157,000.00	371,078
11/22/2022	Patrick G. Enright	Director	Sell	4,974	$149.48	$743,513.52	19,112
11/14/2022	Finbar Larkin	SVP	Sell	197	$149.33	$29,418.01	19,409
11/10/2022	Bruce C. Cozadd	CEO	Sell	2,000	$150.00	$300,000.00	372,028
11/10/2022	Samantha Pearce	SVP	Sell	1,063	$155.00	$164,765.00	11,309
10/3/2022	Bruce C. Cozadd	CEO	Sell	45,185	$134.93	$6,096,812.05	374,028
9/7/2022	Finbar Larkin	SVP	Sell	63	$150.00	$9,450.00	19,606
9/6/2022	Bruce C. Cozadd	CEO	Sell	7,703	$153.18	$1,179,945.54	353,311
8/18/2022	Peter Gray	Director	Sell	8,000	$158.00	$1,264,000.00	14,234
8/15/2022	Patricia Carr	CAO	Sell	2,142	$160.06	$342,848.52	5,934
8/4/2022	Samantha Pearce	SVP	Sell	531	$155.00	$82,305.00	11,309
8/1/2022	Bruce C. Cozadd	CEO	Sell	7,301	$154.31	$1,126,617.31	354,311
7/12/2022	Samantha Pearce	SVP	Sell	532	$155.00	$82,460.00	11,309
7/5/2022	Bruce C. Cozadd	CEO	Sell	8,775	$157.28	$1,380,132.00	351,912
7/5/2022	Christopher J. Tovey	COO	Sell	5,209	$160.00	$833,440.00	14,663
6/27/2022	Samantha Pearce	SVP	Sell	8,508	$155.00	$1,318,740.00	11,309

SEC Filings (Institutional Ownership Changes) for Jazz Pharmaceuticals (NASDAQ:JAZZ)

89.14% of Jazz Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Jazz Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
6/3/2025	Inspire Investing LLC	5,547	$0.69M	0.1%	N/A	0.009%
5/28/2025	Strs Ohio	16,445	$2.04M	0.0%	N/A	0.027%
5/28/2025	Ellsworth Advisors LLC	37,338	$4.64M	1.2%	-1.6%	0.061%
5/23/2025	Twin Lakes Capital Management LLC	1,615	$0.20M	0.1%	-15.7%	0.003%
5/21/2025	Acadian Asset Management LLC	730	$90K	0.0%	N/A	0.001%
5/21/2025	Geneos Wealth Management Inc.	375	$47K	0.0%	+57.6%	0.001%
5/20/2025	Intech Investment Management LLC	31,359	$3.89M	0.0%	+0.4%	0.051%
5/20/2025	Focus Partners Wealth	4,623	$0.57M	0.0%	+3.4%	0.008%
5/19/2025	Bayforest Capital Ltd	1,795	$0.22M	0.1%	N/A	0.003%
5/19/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	197,174	$24.48M	0.0%	+4.2%	0.320%
5/16/2025	Woodline Partners LP	102,050	$12.67M	0.1%	+31.6%	0.166%
5/16/2025	Dean Capital Management	16,492	$2.05M	0.9%	+2.3%	0.027%
5/16/2025	Faithward Advisors LLC	13,766	$1.71M	0.3%	-3.9%	0.022%
5/16/2025	United Services Automobile Association	3,840	$0.47M	0.0%	N/A	0.006%
5/16/2025	Great Lakes Advisors LLC	55,210	$6.85M	0.1%	+51.5%	0.090%
5/16/2025	Goldman Sachs Group Inc.	351,609	$43.65M	0.0%	+147.7%	0.570%
5/16/2025	Dynamic Technology Lab Private Ltd	6,190	$0.77M	0.1%	N/A	0.010%
5/16/2025	Petrus Trust Company LTA	6,272	$0.78M	0.1%	N/A	0.010%
5/16/2025	NFJ Investment Group LLC	24,023	$2.98M	0.1%	N/A	0.039%
5/16/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	52,475	$6.52M	0.0%	-14.1%	0.085%
5/16/2025	Hancock Whitney Corp	2,649	$0.33M	0.0%	N/A	0.004%
5/16/2025	Estuary Capital Management LP	309,750	$38.46M	9.3%	+33.2%	0.503%
5/16/2025	Alliancebernstein L.P.	117,949	$14.64M	0.0%	+33.5%	0.191%
5/16/2025	AQR Arbitrage LLC	90,138	$11M	0.3%	+115.5%	0.146%
5/16/2025	AQR Capital Management LLC	490,307	$59.82M	0.1%	-8.1%	0.796%
5/16/2025	Advisors Asset Management Inc.	3,566	$0.44M	0.0%	-16.7%	0.006%
5/16/2025	Amundi	72,068	$8.71M	0.0%	-10.5%	0.117%
5/16/2025	Adage Capital Partners GP L.L.C.	13,000	$1.61M	0.0%	N/A	0.021%
5/15/2025	EP Wealth Advisors LLC	3,303	$0.41M	0.0%	+87.4%	0.005%
5/15/2025	Cubist Systematic Strategies LLC	10,523	$1.31M	0.0%	+2,243.7%	0.017%
5/15/2025	Royal Bank of Canada	67,614	$8.39M	0.0%	+96.5%	0.110%
5/15/2025	Quarry LP	1,200	$0.15M	0.0%	-29.4%	0.002%
5/15/2025	Nomura Holdings Inc.	10,217	$1.27M	0.0%	+27.4%	0.017%
5/15/2025	Mubadala Investment Co PJSC	18,986	$2.36M	0.0%	-5.1%	0.031%
5/15/2025	Baird Financial Group Inc.	4,341	$0.54M	0.0%	N/A	0.007%
5/15/2025	Panagora Asset Management Inc.	87,293	$10.84M	0.1%	+4,717.5%	0.142%
5/15/2025	GMT Capital Corp	672,900	$83.54M	4.4%	+32.3%	1.092%
5/15/2025	Vident Advisory LLC	26,209	$3.25M	0.0%	-10.4%	0.043%
5/15/2025	Evergreen Capital Management LLC	2,886	$0.36M	0.0%	-29.6%	0.005%
5/15/2025	The Manufacturers Life Insurance Company	515,407	$63.99M	0.1%	+45.8%	0.836%
5/15/2025	Clough Capital Partners L P	32,550	$4.04M	0.5%	-23.3%	0.053%
5/15/2025	Driehaus Capital Management LLC	90,550	$11.24M	0.1%	N/A	0.147%
5/15/2025	Canada Pension Plan Investment Board	176,600	$21.93M	0.0%	-6.6%	0.287%
5/15/2025	Iron Triangle Partners LP	130,000	$16.14M	2.6%	N/A	0.211%
5/15/2025	State of Wyoming	3,320	$0.41M	0.1%	-25.1%	0.005%
5/15/2025	Trexquant Investment LP	64,078	$7.96M	0.1%	+30.0%	0.104%
5/15/2025	Oak Associates Ltd. OH	22,095	$2.74M	0.2%	-0.9%	0.036%
5/15/2025	OMERS ADMINISTRATION Corp	14,035	$1.74M	0.0%	+13.3%	0.023%
5/14/2025	CreativeOne Wealth LLC	1,631	$0.20M	0.0%	N/A	0.003%
5/14/2025	Rafferty Asset Management LLC	3,465	$0.43M	0.0%	-19.8%	0.006%
5/14/2025	Corebridge Financial Inc.	66,765	$8.29M	0.0%	-2.4%	0.108%
5/14/2025	Freedom Investment Management Inc.	2,120	$0.26M	0.0%	-11.9%	0.003%
5/14/2025	MetLife Investment Management LLC	33,545	$4.17M	0.0%	-1.6%	0.054%
5/14/2025	Synovus Financial Corp	3,699	$0.46M	0.0%	-80.7%	0.006%
5/14/2025	Campbell & CO Investment Adviser LLC	29,592	$3.67M	0.3%	N/A	0.048%
5/14/2025	Systematic Financial Management LP	386,903	$48.03M	1.4%	+2.8%	0.628%
5/14/2025	Jump Financial LLC	4,427	$0.55M	0.0%	N/A	0.007%
5/14/2025	Hotchkis & Wiley Capital Management LLC	29,740	$3.69M	0.0%	-28.4%	0.048%
5/14/2025	SVB Wealth LLC	290	$36K	0.0%	N/A	0.000%
5/14/2025	Northwestern Mutual Wealth Management Co.	3,434	$0.43M	0.0%	+21.4%	0.006%
5/14/2025	Ameriprise Financial Inc.	1,675,762	$208.03M	0.1%	-8.3%	2.719%
5/14/2025	Martingale Asset Management L P	8,641	$1.07M	0.0%	+116.8%	0.014%
5/14/2025	Groupama Asset Managment	8,718	$1.07M	0.0%	+7.6%	0.014%
5/14/2025	Hsbc Holdings PLC	2,378	$0.29M	0.0%	-17.2%	0.004%
5/14/2025	Fuller & Thaler Asset Management Inc.	1,331,011	$165.25M	0.6%	+41.7%	2.160%
5/14/2025	Wellington Management Group LLP	100,962	$12.53M	0.0%	+141.5%	0.164%
5/13/2025	Northern Trust Corp	525,163	$65.20M	0.0%	+0.8%	0.852%
5/13/2025	Brooklyn Investment Group	552	$69K	0.0%	+411.1%	0.001%
5/13/2025	Raymond James Financial Inc.	155,066	$19.25M	0.0%	+67.9%	0.252%
5/13/2025	Cresset Asset Management LLC	14,536	$1.81M	0.0%	-13.7%	0.024%
5/13/2025	State of New Jersey Common Pension Fund D	20,291	$2.52M	0.0%	-11.5%	0.033%
5/13/2025	American Century Companies Inc.	188,062	$23.35M	0.0%	+17.2%	0.305%
5/13/2025	Brandywine Global Investment Management LLC	391,276	$48.58M	0.4%	+2.5%	0.635%
5/13/2025	Dimensional Fund Advisors LP	2,328,430	$289.07M	0.1%	+14.4%	3.778%
5/13/2025	Fox Run Management L.L.C.	10,339	$1.28M	0.2%	+133.9%	0.017%
5/13/2025	Boston Partners	11,150	$1.38M	0.0%	+21.6%	0.018%
5/13/2025	Caitong International Asset Management Co. Ltd	647	$80K	0.1%	N/A	0.001%
5/13/2025	Prudential PLC	4,174	$0.52M	0.0%	N/A	0.007%
5/13/2025	HighTower Advisors LLC	8,664	$1.08M	0.0%	-10.2%	0.014%
5/12/2025	Nuveen LLC	502,310	$62.36M	0.0%	N/A	0.815%
5/12/2025	Cooper Financial Group	4,518	$0.56M	0.1%	+4.2%	0.007%
5/12/2025	Virtu Financial LLC	9,362	$1.16M	0.1%	N/A	0.015%
5/12/2025	Invesco Ltd.	229,540	$28.50M	0.0%	+11.7%	0.372%
5/12/2025	Atlas Capital Advisors Inc.	4,614	$0.57M	0.1%	+1,378.8%	0.007%
5/12/2025	Covestor Ltd	1,163	$0.15M	0.1%	+12.8%	0.002%
5/12/2025	JPMorgan Chase & Co.	1,662,042	$206.34M	0.0%	+4.7%	2.697%
5/12/2025	Connor Clark & Lunn Investment Management Ltd.	132,415	$16.44M	0.1%	+18.2%	0.215%
5/12/2025	Measured Wealth Private Client Group LLC	3,301	$0.41M	0.1%	N/A	0.005%
5/12/2025	Townsquare Capital LLC	3,966	$0.49M	0.0%	+12.0%	0.006%
5/12/2025	Swiss National Bank	111,300	$13.82M	0.0%	-3.6%	0.181%
5/12/2025	Maryland State Retirement & Pension System	2,817	$0.35M	0.0%	-19.0%	0.005%
5/9/2025	Deutsche Bank AG	14,416	$1.79M	0.0%	-10.0%	0.023%
5/9/2025	Ontario Teachers Pension Plan Board	24,944	$3.10M	0.0%	+95.8%	0.040%
5/9/2025	Charles Schwab Investment Management Inc.	615,717	$76.44M	0.0%	+0.0%	0.999%
5/9/2025	CM Management LLC	20,000	$2.48M	2.4%	+33.3%	0.032%
5/9/2025	AXS Investments LLC	5,400	$0.67M	0.2%	N/A	0.009%
5/9/2025	Vanguard Group Inc.	6,017,403	$747.06M	0.0%	-0.3%	9.763%
5/9/2025	PNC Financial Services Group Inc.	5,128	$0.64M	0.0%	+8.0%	0.008%
5/9/2025	LSV Asset Management	2,466,166	$306.18M	0.7%	-2.6%	4.001%
5/8/2025	Jefferies Financial Group Inc.	11,213	$1.39M	0.0%	N/A	0.018%

Data available starting January 2016

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products for unmet medical needs in the United States, Europe, and internationally. The company offers Xywav for cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia; Xyrem to treat cataplexy or EDS with narcolepsy; Epidiolex for seizures associated with Lennox-Gastaut and Dravet syndromes, or tuberous sclerosis complex; Zepzelca to treat metastatic small cell lung cancer, or with disease progression on or after platinum-based chemotherapy; Rylaze for acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Defitelio to treat severe hepatic veno-occlusive disease; and Vyxeos for newly-diagnosed therapy-related acute myeloid leukemia. It also develops Zanidatamab to treat HER2-expressing gastroesophageal adenocarcinoma (GEA), and patients with HER2-expressing metastatic GEA; Zepzelca for the treatment of patients with select relapsed/refractory solid tumors based on limited response in three solid tumor cohorts; JZP815, a pan-RAF kinase inhibitor that targets components of the mitogen-activated protein kinase; JZP898, a conditionally-activated interferon alpha molecule; Epidiolex to treat LGS, DS, and TSC; Suvecaltamide to treat parkinson's disease tremor; JZP150, a fatty acid amide hydrolase inhibitor program to treat post-traumatic stress disorder; and JZP441 to treat narcolepsy, IH, and other sleep disorders. The company has licensing and collaboration agreements with XL-protein GmbH to extend the plasma half-life of selected asparaginase product candidates; Redx Pharma plc for preclinical activities Ras/Raf/MAP kinase pathway program; and Autifony Therapeutics Limited on discovering and developing drug candidates targeting two different ion channel targets associated with neurological disorders. The company was incorporated in 2003 and is headquartered in Dublin, Ireland.

Today's Range

Now: $110.29

$109.48

$111.45

50 Day Range

MA: $107.72

$97.81

$120.05

52 Week Range

Now: $110.29

$95.49

$148.06

Volume

673,268 shs

Average Volume

834,338 shs

Market Capitalization

$6.80 billion

P/E Ratio

15.53

Dividend Yield

N/A

Beta

0.33

Who are the company insiders with the largest holdings of Jazz Pharmaceuticals?: Jazz Pharmaceuticals' top insider shareholders include:
Bruce C Cozadd (CEO)
Seamus Mulligan (Director)
Robert Iannone (CMO)
Neena M Patil (EVP)
Philip L Johnson (CFO)
Mary Elizabeth Henderson (SVP)
Rick E Winningham (Director)
Patricia Carr (CAO)
Mark Douglas Smith (Director)
Learn More about top insider investors at Jazz Pharmaceuticals.
Who are the major institutional investors of Jazz Pharmaceuticals?: Jazz Pharmaceuticals' top institutional investors include:
Vanguard Group Inc. — 9.76%
LSV Asset Management — 4.00%
Dimensional Fund Advisors LP — 3.78%
Ameriprise Financial Inc. — 2.72%
JPMorgan Chase & Co. — 2.70%
Fuller & Thaler Asset Management Inc. — 2.16%
Learn More about top institutional investors of Jazz Pharmaceuticals stock.
Which major investors are selling Jazz Pharmaceuticals stock?: Within the previous quarter, JAZZ stock was sold by these institutional investors:
Pacer Advisors Inc.
Ameriprise Financial Inc.
LSV Asset Management
AQR Capital Management LLC
Allianz Asset Management GmbH
Vanguard Group Inc.
Bessemer Group Inc.
Federated Hermes Inc.
In the previous year, company insiders that have sold Jazz Pharmaceuticals company stock include:
Bruce C Cozadd (CEO)
Seamus Mulligan (Director)
Robert Iannone (CMO)
Neena M Patil (EVP)
Philip L Johnson (CFO)
Learn More investors selling Jazz Pharmaceuticals stock.
Which major investors are buying Jazz Pharmaceuticals stock?: During the last quarter, JAZZ stock was acquired by institutional investors including:
Nuveen LLC
Fuller & Thaler Asset Management Inc.
Perpetual Ltd
Dimensional Fund Advisors LP
Goldman Sachs Group Inc.
Boston Trust Walden Corp
Zurcher Kantonalbank Zurich Cantonalbank
GMT Capital Corp
During the last year, these company insiders have bought Jazz Pharmaceuticals stock:
Bruce C Cozadd (CEO)
Seamus Mulligan (Director)
Learn More investors buying Jazz Pharmaceuticals stock.